This modulation of the gut-liver axis highlights the broader implications of silymarin in integrative therapy for liver health
Both are known for their regenerative properties but work differently and may serve unique purposes depending on your recovery goals
Herbert BS, Wright WE, Shay JW
Overall, the reduction was modest but meaningful at the population level, amounting to about 7 fewer cases of any substance use disorder (including nicotine) for every 1,000 people treated
Supported by: Wellcome Trust, Royal Society, NIHR, University of Exeter Disclosure: A.E
It is still investigational and not approved anywhere, with possible FDA approval around 2027 (GoodRx)